Ready to submit? Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window)

Journal overview

Artificial Cells, Nanomedicine, and Biotechnology is an interdisciplinary journal, publishing high-quality open access research at the convergence of artificial cells, nanomedicine and health-related biotechnology.

The journal places an emphasis on original research that demonstrates game-changing and disruptive technologies, new concepts and innovative experimental approaches. Articles featuring translational approaches such as clinical implementation may also be published in the journal.

For work to be published it must be of significant interest to the artificial cell , nano health and biotechnology communities and must fall under one of the key subject areas listed below:

Artificial cells:

  • synthetic biology, synthetic organelles, build-a-cell
  • artificial exosomes/extracellular vesicles
  • synthetic genomics, self-assembly, origins of life
  • application of artificial cells as:
    - biotherapeutics and immunotherapeutic (including stem cell therapy)
    - blood substitutes oxygen therapeutics
    - novel carriers for therapeutics (e.g. vaccines, drugs)
  • bio-immunosorbents therapy


Nanomedicine and biotechnology:

  • bio/molecular nanosystems, nanoparticles including nanoscale bio/therapeutics and nano drug carriers, extracellular vesicles, smart and stimuli responsive nanobiosystems
  • human physiology mimicking models, aka organ-on-chip
  • nanotoxicity, nanotoxicology, biomedical sensors including sensor fusion
  • mechanobiology, mechanopharmacology, mechanomedicine, precision nanomedicine
  • nanofabrication, nanolithography and nanopatterning for biomedical applications
  • single particle and single cell analysis, biomedical imaging, nanobiotechnology


The convergence of information science, nano-scale science and molecular biology - nano-bio-info-cogno:

  • bioconvergance and nano-bio-info-cogno network
  • integrated nano-bio-technology platforms including bioinformatics, cognition and prediction


The journal accepts original papers, reviews, editorials (by invitation only), and preliminary communications. Articles featuring translational approaches such as clinical implementation may also be published.

Artificial Cells, Nanomedicine, and Biotechnology operates a single-anonymized peer review policy.

All articles will be made freely and permanently available online through gold open access publication.

Read the Instructions for Authors for information on how to submit your article.

Read full aims and scope

Latest issues